|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02389 BJ HEALTH
Nominal 
0.081 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 30,279 | -60.465% | 157,200 | 149,945 | 140,346 | 166,484 |
| Cost of Sales | (26,485) | -52.867% | (114,747) | (114,265) | (101,872) | (119,972) |
| Gross Profit | 3,794 | -81.397% | 42,453 | 35,680 | 38,474 | 46,512 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,012) | 140.960% | (46,392) | (5,751) | (15,163) | (10,109) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (507) | -93.655% | (15,875) | (30,434) | (23,020) | (43,498) | |
| Profit / (Loss) before Taxation | (44,299) | 46.143% | (102,473) | (119,421) | (68,778) | (102,696) | |
| Taxation | 2,857 | 185.700% | 477 | 3,846 | 7,057 | 3,891 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,645 | 12590.789% | 1,088 | (643) | (161) | 1,109 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (31,797) | 8.760% | (100,908) | (116,218) | (61,882) | (97,696) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 4,146 | -- | (3,629) | (4,617) | (15,231) | (12,990) |
| Depreciation & Amortisation | 11,913 | 12.877% | 21,680 | 21,721 | 24,211 | 26,007 |
| Directors' Emoluments | -- | -- | -- | 8,083 | 6,491 | 5,707 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.520 | 8.333% | -1.670 | -1.920 | -1.010 | -1.610 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.004) | (0.006) | (0.007) | (0.005) |
| NBV per share ($) | 0.276 | -- | 0.274 | 0.283 | 0.311 | 0.336 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -31,797 |
| %Change | 8.760% |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.276 |